Addressing IP Barriers in the Context of a Pandemic Treaty
Tackling the question of how to address the needs for sharing scientific research is fundamental to any pandemic treaty discussion.

Tackling the question of how to address the needs for sharing scientific research is fundamental to any pandemic treaty discussion.

The use of fair, reasonable and non-discriminatory (“FRAND”) terms in the licensing of intellectual property rights could foster cooperation in pandemics.

In academia, many of the scientists who are recognized as inventors on patents see little economic gain from these agreements.

Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.

The pandemic has laid bare the lack of regulation for the sharing of intellectual property needed for an effective and equitable response.

The COVID-19 pandemic has brought into sharp relief longstanding equity problems surrounding the allocation of newly developed vaccines.

Going forward, practical solutions should focus on scaling up manufacturing and supply, and improving access and affordability.

An explanation of the WTO waiver of COVID-19 intellectual property, what the U.S. declaration of support means, and likely effects of the waiver.

Should a waiver be issued, there is no legal mechanism that can compel the transfer of certain types of know-how or trade secrets.
